TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

406.10$ -1.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Amgen Inc (AMGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 4,002 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow AMGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
2,760 538 689 2,459 3,571 4,771 1,391 2,280 4,684 1,603 2,189 4,002 12,478
895 1,380 1,399 1,400 1,396 1,397 1,387 1,341 1,307 1,132 1,116 -1,116 2,439
-149 473 103 157 136 134 85 157 127 125 75 -75 252
53 -898 -692 122 856 2,079 -1,016 -759 1,663 -1,866 -721 721 -203
248 249 230 238 257 371 411 369 436 642 712 513 2,303
-262 -27,089 -217 -217 -210 -402 -447 -389 -414 -693 -716 -569 -2,392
1,140 1,140 1,208 1,209 1,210 1,205 1,279 1,280 1,282 1,283 1,358 1,362 5,285
0.0 0.0 – – – -200 – – – – – – –
– – – – -2,200 0.0 -2,500 -1,000 -1,500 0.0 3,131 0.0 1,631
-2,005 2,754 -1,708 -2,649 -3,651 -1,407 -4,107 -2,673 -2,853 -1,226 1,436 -1,482 -4,125
493 -23,797 -1,236 -407 -290 2,962 -3,163 -782 1,417 -316 2,909 1,951 5,961
2,760 289 459 2,221 3,314 4,400 980 1,911 4,248 961 1,477 3,489 10,175

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?